Brink's Company (BCO) 27.93 $BCO 14.6% Return Seen to

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Brink's Company (BCO) 27.93 $BCO

14.6% Return Seen to Date on SmarTrend Brink's Call (BCO)
Comtex SmarTrend(R) - Fri Mar 20, 11:44AM CDT
SmarTrend identified an Uptrend for Brink's (NYSE:BCO) on December 23rd, 2014 at $24.02. In approximately 3 months, Brink's has returned 14.64% as of today's recent price of $27.53.
BCO: 27.93 (+0.80)

How the Cannabis Industry Is Protecting Its Cash & Crop
ACCESSWIRE - Mon Mar 16, 7:42AM CDT
CORAL GABLES, FL / ACCESSWIRE / March 16, 2015 / A major debate has arisen with regard to the recent legalization efforts by states to support programs for recreational and medicinal marijuana. To date, nearly half of the US has some kind of law in place to govern the sale of cannabis. The takes into account several forms ranging from the raw plant to highly concentrated oils used for infusing edible products. At this point, no matter your stance, it seems as though the US is being taken by storm and a new industry is upon us. Not only does this open added opportunity for business owners to open their own dispensaries but it also creates an opening for other markets to enter the space.
BCO: 27.93 (+0.80), ADT: 40.35 (+0.98)

Brink's to Participate in Bank of America Merrill Lynch 2015 Smid Cap Conference on March 17
GlobeNewswire - Tue Mar 10, 8:05AM CDT
The Brink's Company (NYSE:BCO), a global leader in security-related services, will participate in the Bank of America Merrill Lynch Smid Cap Conference to be held on March 17 at the Four Seasons Hotel in Boston, MA. Joe Dziedzic, executive vice president and chief financial officer, is scheduled to present at 10:15 a.m. and will be available to meet with investors throughout the day. The webcast and archived replay of the presentation can be accessed in the Investor Relations section of the company's website at investors.brinks.com.
BCO: 27.93 (+0.80)

Uptrend Call Working As Brink's Stock Rises 13.1% (BCO)
Comtex SmarTrend(R) - Mon Mar 09, 4:50PM CDT
SmarTrend identified an Uptrend for Brink's (NYSE:BCO) on December 23rd, 2014 at $24.02. In approximately 3 months, Brink's has returned 13.10% as of today's recent price of $27.16.
BCO: 27.93 (+0.80)

Brink's Has Returned 17.3% Since SmarTrend Recommendation (BCO)
Comtex SmarTrend(R) - Mon Mar 02, 11:08AM CST
SmarTrend identified an Uptrend for Brink's (NYSE:BCO) on December 23rd, 2014 at $24.01. In approximately 2 months, Brink's has returned 17.34% as of today's recent price of $28.18.
BCO: 27.93 (+0.80)

Brink's (BCO) is in Overbought Territory: What's Next? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Mar 02, 6:37AM CST
Brink's (BCO) is in Overbought Territory: What’s Next?
BCO: 27.93 (+0.80)

Pre-Market Review on Commercial Services and Supplies Equities -- Tyco Intl., ADT Corp., Pitney Bowes, Cintas, and Brink's
PR Newswire - Thu Feb 19, 8:00AM CST
Editor Note: For more information about this release, please scroll to bottom.
TYC: 43.14 (+0.48), CTAS: 82.55 (-1.41), PBI: 23.96 (+0.71), BCO: 27.93 (+0.80), ADT: 40.35 (+0.98)

Tracking William Von Mueffling's Cantillon Capital Management Portfolio - Q4 2014 Update
John Vincent - at Seeking Alpha - Tue Feb 10, 4:43AM CST

KO: 40.65 (+0.63), SIRO: 88.85 (-0.26), FIS: 68.33 (+0.72), HOG: 61.94 (+0.76), CACC: 201.75 (-2.19), ALTR: 36.95 (+0.35), SLH: 51.53 (-0.21), ICE: 236.70 (-0.01), CMPR: 85.09 (+1.77), GWW: 236.15 (-0.91), GOOG: 560.36 (+2.37), BITA: 53.08 (+2.25), CME: 99.75 (+0.08), ST: 57.45 (+0.54), BIDU: 212.69 (-1.88), MSM: 73.13 (+0.12), ABEV: 5.82 (+0.20), WSH: 49.17 (-0.02), ADI: 61.07 (+1.07), GOOGL: 564.95 (+1.28), BCO: 27.93 (+0.80), HRB: 32.90 (+0.61), ECL: 115.27 (+0.26)

The Brink's (BCO) Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Feb 05, 1:10PM CST

BCO: 27.93 (+0.80)

The Brink's beats by $0.05, misses on revenue
Seeking Alpha - at Seeking Alpha - Thu Feb 05, 5:43AM CST

BCO: 27.93 (+0.80)

Brink's Reports Fourth-Quarter Results
PR Newswire - Thu Feb 05, 5:30AM CST
The Brink's Company (NYSE: BCO), a global leader in security-related services, today reported fourth-quarter earnings.
BCO: 27.93 (+0.80)

Notable earnings before Thursday’s open
Seeking Alpha - at Seeking Alpha - Wed Feb 04, 4:30PM CST

FIS: 68.33 (+0.72), PRGO: 172.87 (+2.50), LAZ: 50.64 (+1.07), CHTR: 189.01 (+0.83), LQDT: 9.62 (-0.02), CFX: 48.42 (+0.47), KORS: 66.13 (-0.69), OZM: 12.48 (+0.13), PTEN: 17.89 (-0.03), DLPH: 79.96 (+0.78), DNKN: 48.15 (-0.10), DFT: 34.72 (+1.31), AMSC: 0.70 (-0.01), APO: 22.24 (+0.05), SNCR: 47.24 (+0.64), PRLB: 70.00 (+0.68), CSL: 92.70 (+1.01), SIRI: 3.98 (+0.02), PBH: 42.46 (+0.62), COTY: 23.64 (+0.51), RSTI: 24.29 (+0.68), IT: 83.03 (+1.30), ADS: 294.45 (+2.05), AINV: 7.57 (+0.14), AZN: 72.70 (+1.80), BCE: 42.17 (+0.12), NGD: 3.85 (+0.27), EL: 83.53 (+1.86), BCO: 27.93 (+0.80), RFP: 16.39 (-0.10), ODFL: 80.13 (-0.24), BDX: 144.72 (-0.21), GRA: 97.33 (+1.28), SNA: 143.69 (-0.69), BR: 53.94 (-0.02), BLL: 71.20 (+0.63), GRUB: 45.12 (-0.12), SBH: 34.49 (+0.05), ARW: 63.92 (+1.85), ETR: 79.05 (+1.11), BDC: 92.13 (+1.46), IVC: 19.31 (+0.01), CMI: 138.40 (+0.95), S: 4.95 (-0.04), PPL: 34.36 (+0.67), NUS: 58.38 (-0.29), MMP: 78.94 (-0.74), MMS: 66.39 (+0.99), MSCI: 59.69 (+1.07), MDSO: 49.53 (+0.26), ICE: 236.70 (-0.01), FBP: 6.36 (+0.05), LIOX: 5.59 (-0.02), CI: 128.38 (+0.28), PM: 79.45 (+0.59), EQT: 78.92 (+0.49), GPI: 82.32 (-0.23), ABB: 21.41 (+0.61), GPK: 14.78 (+0.05), GLT: 26.25 (+0.55), EQM: 76.21 (+0.04)

Brink's announces dividend of USD0.10 per share for quarter
M2 - Fri Jan 23, 7:53PM CST
The board of directors of the Brink's Company (NYSE:BCO), a provider of secure transportation and cash management services, approved a quarterly dividend of USD0.10 per share on the company's common stock, it disclosed on Thursday.
BCO: 27.93 (+0.80)

The Brink's Company declares $0.10 dividend
Seeking Alpha - at Seeking Alpha - Thu Jan 22, 9:53AM CST

BCO: 27.93 (+0.80)

Brink's Fourth-Quarter Earnings Release and Conference Call Scheduled for February 5
PR Newswire - Wed Jan 21, 3:45PM CST
The Brink's Company (NYSE: BCO), a global leader in security-related services, will host a conference call on Thursday, February 5, at 11:00 a.m. (ET) to review fourth-quarter financial results, which will be released earlier that day.
BCO: 27.93 (+0.80)

Comparing America's 3 Largest Security And Protection Services
Joseph Cafariello - at Seeking Alpha - Mon Dec 29, 2:38PM CST

MSA: 51.18 (+1.43), BCO: 27.93 (+0.80), ADT: 40.35 (+0.98)

Brink's Exits Cash Handling Operations in the Netherlands
PR Newswire - Wed Dec 24, 7:30AM CST
The Brink's Company (NYSE: BCO) today announced that it has exited the cash handling market in the Netherlands due to the previously disclosed loss of its largest customer in that country. To ensure an orderly exit and transition, Brink's sold its shares of Brink's Netherlands, B.V., for nominal value to Stichting Continuiteit Brink's Nederland, an independent foundation that was formed to benefit the interests of remaining stakeholders including former employees of Brink's, customers and vendors. The foundation has the right to use the Brink's name for up to one year.
BCO: 27.93 (+0.80)

Brink's Down 14.4% Since SmarTrend Downtrend Call (BCO)
Comtex SmarTrend(R) - Thu Dec 11, 11:07AM CST
SmarTrend identified a Downtrend for Brink's (NYSE:BCO) on September 16th, 2014 at $26.02. In approximately 3 months, Brink's has returned 14.37% as of today's recent price of $22.28.
BCO: 27.93 (+0.80)

NYSE stocks posting largest volume increases
AP - Thu Dec 04, 5:03PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on New York Stock Exchange at the close of trading:
HRS: 72.75 (+0.57), BPZ: 0.15 (-0.09), HE: 32.93 (+0.01), MPLX: 73.09 (-0.76), GIL: 59.71 (+0.12), GIL.TO: 75.06 (-0.82), WMS: 28.88 (+0.19), BMS: 46.22 (-0.41), ARO: 3.14 (+0.12), TLYS: 16.70 (+1.09), SAR: 15.45 (+0.17), YDKN: 19.84 (+0.18), CUZ: 10.87 (+0.35), TYL: 125.29 (+1.82), BCO: 27.93 (+0.80), ADC: 34.17 (+0.67)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 26

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 35

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 24

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 35

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 34

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 37

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading

Top 5 Most Recently Viewed Articles

Man Group PLC Highlights Its Strategic Disclosures on Tritax REIT

Updated Category News Views 148

Strategic Position Disclosure by Man Group PLC Man Group PLC is actively sharing its significant interests in the securities market, particularly focusing on its involvement with Tritax Big Box REIT plc. As a key player in the investment landscape, this disclosure marks an important step for the company regarding its strategic holdings. Key Information Pertaining to the...

Continue Reading
TalentLMS and Epignosis Lead the Way in GDPR Compliance

Updated Category News Views 720

TalentLMS and Epignosis Set the Standard for GDPR Compliance TalentLMS, along with its parent company Epignosis, has continuously led the way in providing a fully compliant Learning Management System (LMS) with regards to the General Data Protection Regulation (GDPR). Recent developments affirm that TalentLMS remains the only LMS globally to uphold its commitment to this...

Continue Reading
Zillow and Esusu Forge New Path to Boost Renters' Credit Scores

Updated Category News Views 283

Building Credit for Renters with Zillow and Esusu The recent collaboration between Zillow and Esusu marks a significant step towards empowering renters across the country to build their credit. This partnership allows any renter to report their on-time rent payments, significantly enhancing their credit profiles, for just $20 a year. How the Partnership Works Starting...

Continue Reading
iCrowdNewswire Leverages DeepL for Enhanced Global Communication

Updated Category News Views 121

iCrowdNewswire Enhances Multilingual Capabilities iCrowdNewswire, a prominent international press release distribution company, has embarked on a transformative journey to improve its multilingual services through the introduction of the DeepL API. The integration of DeepL's cutting-edge language AI technology has significantly boosted iCrowdNewswire’s ability to...

Continue Reading
Celebrating Excellence: Top Surgeons Recognized in Endocrine Care

Updated Category News Views 82

Exceptional Recognition for Leading Surgeons in Endocrine Surgery Dr. Jim Norman and Dr. Gary Clayman Acknowledged as Premier Specialists The Hospital for Endocrine Surgery is proud to announce that two of its distinguished surgeons, Dr. Jim Norman and Dr. Gary Clayman, have been honored in the prestigious Castle Connolly Top Doctors list for 2025. This remarkable...

Continue Reading